Peripheral artery disease: vizsgálatok itt: Japán
2 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEfficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Where
- Chūō, Fukuyama, Hakodate, Higashiibaraki, Higashiku, Kanazawa, Kawasaki, Kitakyushu, Kobe, Kusatsu, Matsudo, Musashino-shi, Nagoya, Naka, Ōita, Osaka, Saitama, Sapporo, Shiwa-gun Yahaba-cho, Toyonaka, Yamagata, Yokohama
- Életkor
- 18 év and over
- People
- 1205 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07223593 · EU 2025-523283-21-00 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Hashima-gun, Higashiosaka-shi, Hiroshima, Hokkaido, Ibaraki, Ichinomiya-shi, Inashiki-gun, Kagoshima, Kamakura-shi, Kanazawa, Kitakyushu-shi, Kurume, Kurume-shi, Kusatsu-shi, Kyoto, Maebashi, Matsubara-shi, Nagaoka-Shi, Nagoya, Ogaki-Shi, Ōmihachiman, Oyama-shi, Sakaimachi, Sapporo, Shinjuku-Ku, Takasaki-Shi, Tsukuba, Ube-shi, Urayasu-shi, Yamagata, Yokohama, Yonago-shi
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00